- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230016
Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program (APADHOP)
Evaluation of the Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity
Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse.
The aim of this study is to keep the children in the APA programm during all the treatment lenght.
This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm.
The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The literature and the French Cancer Plan confirm the benefits of physical activity for cancer patients, and underline the importance of developing appropriate physical activity support for children and adolescents, given their specific needs and the societal and public health challenge represented by these budding patients.
Despite the abundance of studies relating to physical activity in oncology, few data are available, particularly in the pediatric and adolescent/young adult population :
- on physical activity interventions initiated early and sustained over time
- on personalized physical activity interventions integrated into the patient's care/life trajectory
- on factors favoring adhesion to an adapted physical activity program [APA] during and/or after cancer treatment
This is a prospective, exploratory, monocentric study to explore these points.
As part of routine management in the immunohaemato-oncology [IHO] department of the Grenoble Alpes University Hospital, a personalized physical activity [PA] program is systematically proposed by a PA professional, with a program adapted to the child, his or her motivations and limitations.
As part of the protocol, a questionnaire-based assessment of motivations and obstacles, as well as quality of life, will be carried out at the start of the PA program and again after 4 to 6 months. Criteria for adherence to the APA program will also be collected.
EXPECTED OUTPUTS
- Propose an organizational model in pediatric oncology for the early and sustained practice of APA with children and adolescents hospitalized for cancer.
- Finalize assessment and follow-up materials for children receiving APA support in pediatric oncology (information leaflets, certificate of no contra-indication to APA, assessment and follow-up form, questionnaire on attitude and motivation to APA, etc.).
- Provide guidance to help young cancer patients adhere more effectively to APA program.
- Participate in the promotion of APA and the development of APA recommendations for children and adolescents treated for cancer, in conjunction with the SFCE (Children Cancer French Society) national working group on APA for children and adolescents with cancer.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Isabelle Schiff, PHD
- Phone Number: +33476766561
- Email: ISchiff@chu-grenoble.fr
Study Contact Backup
- Name: Laura Chambon
- Phone Number: 33 4 76 76 89 35
- Email: lchambon@chu-grenoble.fr
Study Locations
-
-
Isere
-
Grenoble, Isere, France, 38000
- CHU Grenoble Alpes
-
Sub-Investigator:
- cécile perret
-
Contact:
- Isabelle Schiff
- Phone Number: +33476766561
- Email: ISchiff@chu-grenoble.fr
-
Contact:
- Leila Gofti Laroche
- Phone Number: +33625574699
- Email: LGofti-laroche@chu-grenoble.fr
-
Sub-Investigator:
- Mélanie balleeger
-
Sub-Investigator:
- anne pagnier
-
Sub-Investigator:
- gaelle stofleth
-
Sub-Investigator:
- corinne armari alla
-
Sub-Investigator:
- severine bobillier chaumont
-
Sub-Investigator:
- dalila adjaoud
-
Principal Investigator:
- Leila Gofti Laroche
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients aged 3 years to under 18 years under care at Grenoble Alpes University Hospital
- New cancer diagnosis or relapse in the absence of previous APA treatment
- All cancer pathologies:
Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors
- Regardless of therapeutic pathway
- Patient and parents who have not objected to participation after being informed
Exclusion Criteria:
- Patient with a strict medical contraindication to physical activity identified by the referring physician or another specialist physician, particularly the sports physician (unstabilized heart or lung disease, uncontrolled diabetes, etc.)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adhesion to an APA programm
Time Frame: 4 to 6 months
|
Adherence of children and adolescents undergoing cancer treatment to personalized support in Adapted Physical Activity [APA] offered at an early stage and for a minimum duration of 4 to 6 months : patients following the whole APA program/patients included, in percent
|
4 to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Motivation and restraints
Time Frame: 4 to 6 months
|
This outcome is measured through a semi directive questionnaire elaborated by the SENS laboratory (Laboratory of physical exercice and social environment, Grenoble, France). It measures attitudes and motivations that have been identified as key factors in behavior change, within the framework of the main health psychology models of behavior change, such as the theory of planned behavior, the health action process approach, or self-determination theory .In order to measure these constructs, tools adapted to children from 8 years old and scientifically validated were identified in the scientific literature and adapted for the APADHOP project. Children with cancer over 8 years old and one or both parents will answer to questions at the start of the adapted physical activity programm ((APA) and after 4 to 6 months of APA personnalised support. There is no scoring as this is a descriptive outcome (after been analyzed by a humanities and social sciences researcher) |
4 to 6 months
|
Quality of life measure
Time Frame: 4 to 6 months
|
Quality of life will be measured by international validated PedsQL questionnaires V4.0 (paediatric quality of Life Inventory) according to the age of the patient:
Each item of the questionnaire is scored between 0 and 4 and the total score of the questionnaire is between 0 an 100. The higher score means a better quality of life. To be able to measure the score at least 50% of the items must be answered. The results will be analysed only for patients and parents who have answered to the questionnaires at both evaluation time. |
4 to 6 months
|
Representation of physical activity
Time Frame: 4 to 6 months
|
The evaluation of the representation of physical activity Activity of children and parents at diagnosis and after 4 to 6 months of personalized APA support will be performed through a semi directive questionnaire elaborated by the SENS Laboratory (Laboratory of physical exercice and social environment, Grenoble University in France). The questionnaires will be administred to patients over 8 years and parents at the start of the adapted physical activity (APA) programm and after 4 to 6 months of personalized APA support. The effect of personalized support will also be studied by carrying out pre/post analyzes of these dimensions. There is no scoring as this is a descriptive outcome that will be analysed by humanities and social siences university researchers. |
4 to 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Leila Gofti Laroche, MD, CHU Grenoble Alpes
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-A02343-42
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
University of Colorado, DenverRecruitingCancer | Childhood CancerUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Wake Forest University Health SciencesTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Pernille BidstrupOdense University Hospital; Aarhus University Hospital; Aarhus University Hospital... and other collaboratorsCompleted
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Children's Cancer Group, ChinaShanghai Children's Medical Center; Shanghai Municipal Center for Disease Prevention...Recruiting
-
St. Jude Children's Research HospitalRecruiting
Clinical Trials on questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Cliniques universitaires Saint-Luc- Université...Fonds National de la Recherche ScientifiqueNot yet recruitingAlcohol Use Disorder
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | MetastasisUnited States